Midori Yamamoto Selected Research

Midori Yamamoto Research Topics

Disease

3	Macular Degeneration (Age-Related Maculopathy) 07/2020 - 01/2017
3	Wasting Syndrome (Wasting Disease) 01/2015 - 01/2012
2	Pediatric Obesity 11/2022 - 10/2022
2	Obesity 11/2022 - 10/2022
2	Birth Weight (Birth Weights) 01/2022 - 05/2019
2	Polypoidal Choroidal Vasculopathy 10/2019 - 01/2017
2	Choroidal Neovascularization 10/2019 - 01/2017
2	Anaphylaxis (Anaphylactic Shock) 10/2014 - 01/2014
2	Neoplasms (Cancer) 06/2013 - 02/2010
2	Glioma (Gliomas) 05/2010 - 02/2010
2	Carcinogenesis 06/2006 - 05/2006
1	Body Weight (Weight, Body) 01/2022
1	Disease Progression 01/2022
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2022
1	Neurodevelopmental Disorders 11/2021
1	Fetal Distress 09/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Immune System Diseases (Immune Disorders) 10/2014
1	Carcinoma (Carcinomatosis) 06/2013
1	Exanthema (Rash) 01/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2008
1	Inflammation (Inflammations) 04/2007
1	Contact Dermatitis (Eczema, Contact) 04/2007
1	Emphysema 11/2004

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 10/2014 - 04/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 01/2020
2	CadmiumIBA 01/2022 - 05/2019
2	ManganeseIBA 01/2022 - 05/2019
2	MercuryIBA 01/2022 - 05/2019
2	SeleniumIBA 01/2022 - 05/2019
2	Retinaldehyde (Retinal)IBA 01/2017 - 01/2017
2	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2015 - 06/2013
2	Immunoglobulin A (IgA)IBA 10/2014 - 01/2014
2	Immunoglobulin E (IgE)IBA 10/2014 - 01/2014
2	OvalbuminIBA 10/2014 - 01/2014
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2013 - 01/2012
2	CytokinesIBA 04/2007 - 11/2004
1	MicroRNAs (MicroRNA)IBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Therapeutic UsesIBA 01/2022
1	Melanins (Melanin)IBA 01/2022
1	Volatile Organic CompoundsIBA 11/2021
1	Indicators and Reagents (Reagents)IBA 09/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 10/2019
1	Trace Elements (Biometals)IBA 05/2019
1	Polychlorinated Biphenyls (PCBs)IBA 05/2019
1	Retinal Pigments (Pigments, Visual)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	LipidsIBA 01/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	Chenodeoxycholic Acid (Chenix)FDA Link 01/2015
1	Cholic AcidIBA 01/2015
1	Pharmaceutical PreparationsIBA 10/2014
1	Immunoglobulin G (IgG)IBA 10/2014
1	AntibodiesIBA 01/2014
1	VaccinesIBA 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2014
1	A-Form DNA (A-DNA)IBA 06/2013
1	DioxinsIBA 06/2013
1	Selenium-Binding ProteinsIBA 06/2013
1	SodiumIBA 01/2012
1	loxoprofen (CS 600)IBA 01/2012
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2012
1	Voriconazole (Vfend)FDA LinkGeneric 01/2012
1	ResveratrolIBA 05/2010
1	Cytoplasmic DyneinsIBA 02/2010
1	Dyneins (Dynein)IBA 02/2010
1	plexinIBA 03/2008
1	Integrin alpha1beta1IBA 04/2007
1	IntegrinsIBA 04/2007
1	Semaphorins (Semaphorin)IBA 06/2006
1	XenobioticsIBA 05/2006
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2006
1	SmokeIBA 11/2004

Therapy/Procedure

3	Transplantation 01/2022 - 10/2019
1	Therapeutics 01/2017
1	Drug Therapy (Chemotherapy) 02/2010